Startup profile · funding coverage
Revella Health funding, valuation and investors
AI and clinical outreach for Medicare Advantage Stars, risk adjustment, and care-gap closure.
Keep track of Revella Health
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Accelerator
Amount not disclosed · Date not disclosed
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
Not publicly disclosed
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
pre seed · Birmingham, AL
Investors in latest funding
Overview
Revella Health helps Medicare Advantage and ACA Marketplace plans improve Star Ratings, close HEDIS quality gaps, and strengthen risk adjustment by combining AI-enabled clinical intelligence with deployed care teams that create member encounters hard to reach via outreach campaigns alone. Founded by Daniel Yeboah (formerly Beamax Health), the company participated in Prosper HealthTech Accelerator (powered by gener8tor) and relocated headquarters from Toronto to Birmingham, AL. Product work has included the ARIA platform for real-time conversation analysis, documentation, and care-gap/risk signals at the provider level.
Why Revella Health is interesting
MA plan economics hinge on half-star Stars moves and HCC capture. Revella combines AI documentation/care-gap tooling with in-community clinical encounters — and relocated HQ to Birmingham after Prosper HealthTech, tying a payer-quality product to Alabama’s health-tech accelerator.
Product & use cases
Revella sells plans and providers a mix of AI clinical intelligence (care gaps, documentation, risk signals) and operational capacity to close multiple HEDIS gaps and capture diagnoses in real encounters.
- MA plans needing Stars and rebate economics from quality measure improvement
- Plans closing hard-to-reach member care gaps with in-home or practice-deployed encounters
- Provider practices improving documentation and quality reporting under value-based contracts
Key facts
- Focus: Medicare Advantage Stars, HEDIS gap closure, and risk adjustment
- Relocated HQ to Birmingham, AL after Prosper HealthTech Accelerator
- ARIA AI platform for documentation, care gaps, and risk signals (company/accelerator materials)
- Nurse-founded / clinical-ops model that creates member encounters, not only analytics dashboards
Funding history (newest first)
Investors in our directory
Funds linked from Revella Health's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Pairs AI gap/risk detection with clinical teams that create billable, HEDIS-relevant encounters — not software-only chart mining.
-
In-home assessment / retrospective risk vendors direct
Often diagnosis capture without point-of-care quality closure.
-
AI ambient documentation tools adjacent
Note generation; may not own Stars/gap ops for plans.
-
Traditional care-gap outreach call centers incumbent
High volume, lower clinical encounter quality.
Industries
Market / IPO context
Editorial / static context — not a live quote.
Related funding articles
Venture Capital Tracker pieces that cover Revella Health's financing or category context.
FAQs about Revella Health
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.